New Findings from Eli Lilly and Company in the Area of GLP-1 Receptor Agonist Published (Effects of Tirzepatide vs Semaglutide on b-cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test)

Source :: Obesity, Fitness & Wellness Week. June 15, 2024, 86
Publication Year :: 2024
Abstract: 2024 JUN 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on GLP-1 receptor agonist. According to news reporting [...]

Subjects :: Eli Lilly and Co. -- Reports
Diabetes therapy -- Reports
Dextrose -- Reports
Insulin -- Reports
Glucose -- Reports
Type 2 diabetes -- Reports
Physical fitness -- Reports
Pharmaceutical industry -- Reports
Health

Tools